3 June 2025 in Australasian Journal of Plastic Surgery
Background: Calvarial exposure is a recognised complication of surgical and radiotherapeutic treatment of scalp skin cancers. Exposure of the calvarium from this treatment may result in bone desiccation, infection and sequestration, which can pose significant risk to patient morbidity and mortality, and be resource-intensive to treat. Aim: To investigate the risk factors and report the incidence of calvarial exposure in the treatment of scalp malignancies. Methods: A retrospective review of all patients presenting to Liverpool Cancer Therapy Centre between 2016–2022 was conducted. Patients (>18 years) with scalp skin cancers stage T2 or T3 (n = 150) were identified via electronic medical records. Associations between surgical and radiotherapeutic treatment were studied using descriptive statistics. Results: Dual-therapy patients were found to have the highest incidence of calvarial exposure followed by radiotherapy-only patients, with 7.69 per cent of dual-therapy patients, 6.06 per cent of radiotherapy-only patients and 3.95 per cent of surgery-only patients experiencing calvarial exposure. A comparison using the Charlson Comorbidity Index (CCI) was statistically significant, with radiotherapy patients having an average CCI score 0.97 points higher than surgical patients (p < 0.05). In the radiotherapy cohort, the calvarial-exposure population on average received a 23.03 Gy higher dose compared to the non-exposure population. This difference was statistically significant (p = 0.0011). In the surgical cohort, calvarial exposure only occurred in patients treated with skin grafts, either as sole coverage or as part of a transposition flap. Healing was only achieved in calvarial exposure patients who were treated with surgery. Conservative treatment with dressings did not lead to healing. Conclusion: The data indicates a trend towards patients receiving dual-therapy being at higher risk of calvarial exposure than those who receive surgery-only or radiotherapy-only. It also indicates that the incidence of calvarial exposure following treatment of scalp cancer is relatively low. Larger skin surface-area resections, larger radiotherapy doses and a higher CCI score are identified risk factors.